OPXA, SPDE, LDSR, OPGX, EESO, GDSM Stocks to Watch for Monday, August 10th from OTCPicks.com

Our Stocks to Watch tomorrow include Opexa Therapeutics Inc. (Nasdaq: OPXA), Speedus Corp. (Nasdaq: SPDE), Land Star Inc. (OTC: LDSR), Optigenex Inc. (OTC: OPGX), Enzyme Environmental Solutions Inc. (OTC: EESO) and Gold Coast Mining Corp. (OTC: GDSM).

Visit http://www.otcpicks.com/microcap.htm to register for our Daily Market Mover's Digest Newsletter, and Email Stock Watch Alerts.

OPEXA THERAPEUTICS INCORPORATED (NASDAQ: OPXA)

"Up 326.75% on Friday"

Detailed Quote: http://www.otcpicks.com/quotes/OPXA.php

Opexa Therapeutics, Inc. is dedicated to the development of patient-specific cellular therapies for the treatment of autoimmune diseases. The Company’s leading therapy, Tovaxin, is an individualized cellular immunotherapy treatment in Phase IIb clinical development for Multiple Sclerosis (MS). Tovaxin is derived from T-cells isolated from peripheral blood, expanded ex vivo, and reintroduced into the patients via subcutaneous injections. This process triggers a potent immune response against specific subsets of autoreactive T-cells known to attack myelin and, thereby, reduces the risk of relapse over time. Data from the first Phase IIb clinical study showed compelling evidence that Relapsing Remitting MS patients treated with Tovaxin saw overall clinical, MRI, and immunological benefits over the placebo group, including statistical significance for decrease in the Annualized Relapse Rate (ARR), improvement in disability score (EDSS), and improvement in quality of life measures (MSQLI), as well as an excellent safety profile with no serious adverse events related to Tovaxin treatment.

OPXA News:

August 7 - Opexa Announces Stem Cell Agreement with Leading Global Pharmaceutical Company

Opexa Therapeutics, Inc. (Nasdaq: OPXA), a company developing a novel T-cell immunotherapy for multiple sclerosis (MS), today announced that it has entered into an exclusive agreement with Novartis, one of the world’s largest pharmaceutical companies, for the further development of Opexa’s novel stem cell technology. This technology, which has generated preliminary data showing the potential to generate monocyte derived islet cells from peripheral blood mononuclear cells, was in early preclinical development at Opexa.

Under the terms of the agreement, Novartis will acquire the stem cell technology from Opexa and Novartis will have full responsibility for funding and carrying out all research, development and commercialization activities. Opexa will receive an upfront cash payment of $3 million, plus an additional $1 million as a technology transfer fee to be paid over the course of a six month period. Total payments to Opexa, including the upfront payment, the technology transfer fee and development and commercial milestone payments could exceed $50 million not including royalties. Opexa is also eligible to receive royalty payments from the sale of any products resulting from the use of the technology and retains an option on certain manufacturing rights.

“This represents a great opportunity for Opexa,” stated Neil K. Warma, Opexa’s president and chief executive officer. “Novartis is one of the premier pharmaceutical companies and the expertise they bring to this program will undoubtedly advance the technology significantly. This agreement will also allow us to firmly focus our attention on our key clinical asset, Tovaxin®.

SPEEDUS CORPORATION (NASDAQ: SPDE)

"Up 283.95% on Friday"

Detailed Quote: http://www.otcpicks.com/quotes/SPDE.php

Speedus Corp., through its subsidiaries, engages in healthcare, restaurant, and wireless businesses in the United States. The company has co-invested with Siemens Corporate Research, Inc., a subsidiary of Siemens Corporation, in Zargis Medical Corp. to develop advanced diagnostic decision support products and services that automatically analyze acoustical data from a patient to determine physiologically significant features useful in medical diagnosis for primary care physicians, pediatricians, cardiologists, and other healthcare professionals. It owns 90% of F&B Gudtfood, the creator and operator of the original Eurocentric cafe, which operates a store in Manhattan. The company has a portfolio of patents that provide high-speed wireless communication systems. In addition, it offers Local Multipoint Distribution Service (LMDS) license for developing and deploying LMDS technology that is used for various fixed wireless purposes, including wireless local loop telephony, high-speed Internet access, and two-way teleconferencing. The company, formerly known as SPEEDUS.COM, Inc., was founded in 1995 and is based in New York, New York.

SPDE News:

August 7 - Density Dynamics Receives Clearance for Next Generation RamFlash Solid State Drive; Breakthrough Solves SSD Endurance and Performance Concerns

Density Dynamics, a majority owned subsidiary of Speedus Corp. (Nasdaq: SPDE), announced that its Jet.io Solid State Drive has been certified for compliance with Underwriters Laboratories (UL60950-1) as well as FCC (Part 15 class B) standards. Completion of these regulatory certifications marks a new era for Solid State Drive technology with an innovative RamFlash Solid State Drive (RF-SSD) design. This innovation leverages the resiliency and ultra-fast access of DRAM based memory as primary storage with the non-volatile nature of flash memory to deliver breakthrough performance with ultimate durability and data protection.

RamFlash technology is now available in the Density Jet.io RF-SSD and has undergone trials in high-performance, mission-critical applications with customers for trading platforms, real time financial transactions, Cloud Computing and other data-intensive applications. This new technology provides the capability to address the highest write workloads with dramatically higher performance and without the wear out issues of flash based SSDs.

"The Density Dynamics proprietary design utilizes DRAM memory for "hot" core storage functions and flash for backup, all in a uniquely compact 3.5 inch form factor," said Dave Wilkerson, Density's Chief Technical Officer. "The new design employs power and storage management algorithms for alleviating I/O bottlenecks while using dramatically lower power than other RAM based solutions. Our RF-SSD technology represents a new dawn in the evolution of the Solid State Disk market," added Wilkerson.

According to a July 16, 2009 research report by Aaron C. Rakers of Stifel Nicolaus, "...our checks continue to suggest that there is no viable competitor to STEC in enterprise SSDs until mid-2010..." Shant Hovnanian, Density's Chief Executive Officer said, "We see our breakthrough product giving IT managers and array system providers a better alternative to flash-only drives, such as those from STEC, for applications with the highest performance requirements."

ABOUT DENSITY DYNAMICS

Density Dynamics, a majority owned subsidiary of Speedus Corp., is a pioneer in the solid-state storage and I/O acceleration technology. Its high performance RamFlash solid-state storage and computing devices are designed to reduce I/O bottlenecks while also reducing power, cooling, and rack space requirements.

LAND STAR INCORPORATED (OTC: LDSR)

"Up 168.75% on Friday"

Detailed Quote: http://www.otcpicks.com/quotes/LDSR.php

Land Star, Inc. operates as a polymer redeployment and polymer reactivation company. Through its majority owned subsidiary, Rebound Rubber Corporation, the company develops certain technology rights for the recycling of rubber. It also, along with its subsidiary PolyTek Rubber & Recycling, Inc., produces crumb rubber using reduction technologies, including ambient grind, cryogenic, and wet grind systems. Land Star also maintains exclusive North American rights to a proven devulcanization technology, which fundamentally changes the way recycled rubber is used. This technology creates a new raw material, Activated Modified Rubber, which may be compounded with natural and synthetic rubber or used directly in new vulcanized products.

LDSR News:

August 7 - LandStar, Inc. Finalizes Beijing Blue Sky Petroleum

Land Star Inc. (OTC: LDSR) operating subsidiary, Hubei Chuguan Industry Co. Ltd., has signed a contract to supply VRUJ-5-type oil and gas recovery units to be used in gas stations with Beijing Blue Sky Petroleum Ltd. The total value of this transaction is 1.96 million RMB Chinese Yuan, or approximately $285,000 USD.

Hubei Chuguan recently held a seminar, hosting a variety of industry experts and government officials to discuss oil treatment and recycling options for the Yangtze River Delta area, comprising 25 major cities, including Shanghai, Nanjing, Hangzhou, Shenzhen, and Guangzhou. The seminar covered a comprehensive analysis of the problems relevant to oil and gas recovery in the petrochemical supply chain, based on the theme of environmental protection. The seminar included policy analysis, special reports, technical seminars, question and answer sessions and provided participants with a three-dimensional solution for an oil and gas recovery system transformation in terms of technology, capital and services. The three-dimensional solutions put forward by Hubei Chuguan were ultimately endorsed by the seminar participants, laying important groundwork for the Company's further development of its business model. For example, seminars such as the above mentioned one, and networking resulting in the company securing an $800,000.00 contract as per the company's news release of April 15, 2009.

VRUJ-5-type oil and gas recovery units are the work horse product for the company. It is highly regarded as the industry's leading edge oil treatment and recycling solution. The company intends to provide further updates on other VRUJ-5-type finalized transactions, and further ongoing developments and enhancements of the unit on a timely basis.

In other Company news, the company intends to release its Q2 financials on or before August 15th due date. These documents are currently being translated from Chinese to North American standards. The company is responding to its shareholders requests that the information currently displayed on Pink Sheets be updated. This has been recently completed. The company expects Pink Sheets to display the update(s) shortly in accordance with their verification policies.

OPTIGENEX INCORPORATED (OTC: OPGX)

"Up 66.67% on Friday"

Detailed Quote: http://www.otcpicks.com/quotes/OPGX.php 

Optigenex inc. is a formulator, distributor and provider of proprietary next generation skin care, supplements and bulk ingredient featuring AC-11® (Formerly known as C-MED-100®) a patented compound as it core product. AC- 11® is the bioactive, water soluble form of the medicinal herb Uncaria tomentosa.

OPGX News:

August 6 - Optigenex Inc. Announces Rollout of Activar® AC-11® Oral Supplements and Activar® AC-11® Next Generation Skin Care Products in Turkey Through Its Middle Eastern Distribution Partner Ekson Farma, Istanbul

Company Expects Commercial Sales to Begin in Early Fall 2009 Through Pharmacies and Other Healthcare Distribution Channels (Financial Terms Were Not Disclosed)

Optigenex Inc. (OTC: OPGX) announced that its partner Ekson Farma is prepared to launch its family of AC-11® oral supplements and skin care products under the brand name Activar® for distribution throughout the major pharmacies in Turkey. Under an exclusive license signed in early 2008, Ekson has invested significant capital, resources and time in determining market acceptance of Optigenex's patented technology and has also devoted considerable efforts towards clinical and scientific research to broaden the market applications for its unique anti-aging products. The agreement and subsequent commercialization by Ekson sets the stage for the introduction of AC-11® to educated and health-conscious Turkish consumers and represents another important strategic initiative in the company's plans to establish AC-11® as a recognized international brand.

All-natural, and standardized at a minimum of 8 per cent Carboxy Alkyl Esters ("CAEs(TM)"), AC-11® is the only patented aqueous extract of the Uncaria species that can make the following therapeutic claims ("DNA repair, Immune enhancement and Inhibition of pro-inflammatory agents") which are validated by a broad spectrum of scientific and clinical studies.

AC-11® already has gained a major foothold in Japan and has been introduced in other select territories of Asia as a branded ingredient used by over 100 manufacturers and distributors in a variety of anti-aging cosmetic, cosmeceutical and dietary supplement products. With their regional alliance together, Optigenex and Middle Eastern based Ekson Farma anticipate similar market penetration, growth and expansion for AC-11®

Daniel Zwiren, president and CEO of Optigenex Inc., said, "We are delighted to have a company with the scientific pedigree and reputation of Ekson Farma as part of our growing list of marketing and distribution partners. Moreover, we believe the unique scientific properties of AC-11® along with Ekson's research will allow us to grow our business rapidly in this key geographic region."

Doctor Yaman Er, president of Ekson Farma, added, "We are very pleased with the reception AC-11® has received and attribute this attention to the key differentiators of AC-11® supported by clinical and scientific studies. Those studies validate the efficacy of this all-natural ingredient, which is harvested in the Amazon Rainforest and manufactured by Centroflora Group Botucatu, Brazil. Consumer demand in our market is driven by new and result-oriented technologies. We believe our alliance with Optigenex provides us with the opportunity to introduce Turkey and the Middle East to the next major brand in oral and topical applications."

ABOUT EKSON FARMA

Founded in 1994, Ekson Farma is an applied sciences and marketing company focused on providing wellness solutions and related technologies to physicians, pharmacies and the general medical community. Ekson's strategy is to select superior and innovative products validated by clinical and scientific studies, establish consumer and physician acceptance through test marketing and ultimately distribute those products with the goal of improving the quality of life for health conscious consumers and patients. Ekson through its collaboration with research partner OKSANTE LABORATORIES is noted for its development of diagnostic tools utilizing DNA sequencing and molecular diagnostics with an emphasis on early detection of disease and DNA mutations.

ENZYME ENVIRONMENTAL SOLUTIONS INCORPORATED (OTC: EESO)

"Up 42.31% on Friday"

Detailed Quote: http://www.otcpicks.com/quotes/EESO.php

Enzyme Environmental Solutions, Inc. engages in the manufacture of industrial and agricultural enzyme products in the United States. It offers enzyme products solution based on its proprietary formulas. The company's products include organic stain erasing pen, enzyme carpet spotter, enzyme glass and stainless steel cleaner, enzyme grease digester, industrial D cleaner, enzyme mold cleaner, rinse free cleaner, enzyme odor eliminator, and pet stain and odor remover. It was formerly known as Cucos, Inc. and changed its name to Enzyme Environmental Solutions, Inc. in March 2008. The company is headquartered in Fort Wayne, Indiana.

EESO News:

July 15 - Skymark Research Initiates Complimentary Research Coverage On Enzyme Environmental Solutions, Inc.

Skymark Research, a leading provider of small- and micro-cap independent investment research, recently initiated coverage on Enzyme Environmental Solutions, Inc. (OTC: EESO). Skymark Research is currently offering a complimentary trial subscription.

ABOUT SKYMARK RESEARCH

Skymark Research is a leading provider of independent investment research in North America. Our services include research analysis on the small- and micro-cap markets, real-time news and financial data, market commentary and the SMR newsletter. Skymark Research's staff of small-cap investment professionals is dedicated to providing the small market's investment community with the tools and avenues necessary to make the important investment decisions.

GOLD COAST MINING CORPORATION (OTC: GDSM)

"Up 36.36% on Friday"

Detailed Quote: http://www.otcpicks.com/quotes/GDSM.php 

Gold Coast Mining Corp. is pursuing mining acquisitions and joint ventures. The Company currently has a joint venture with Western Sierra Mining Corp. for its Ore Cache and SunGold Mines located in Arizona. The Company currently has 444,887,086 shares issued and outstanding.

GDSM News:

August 5 - Gold Coast Mining Announces Stock Dividend

Gold Coast Mining Corp. (OTC: GDSM), announced that its Board of Directors has set a record date of August 31, 2009, for the proposed dividend of the common stock held in Max Media Group, Inc. The Board declared a dividend of one share of common stock of Max Media for every thirty (30) shares of Gold Coast Mining common stock held by shareholders on August 31, 2009.

It is management's expectation that Max Media will be trading under its new symbol by the record date. Additionally, Max Media is preparing its financials to file with Pink Sheets, which will allow the company to have current financial information available.

Jason Cooper, Interim CEO of Gold Coast Mining Corp., commented, "The setting of the record date for our previously announced dividend, as well as the distribution rate, is a big step forward for the Company in its pursuit of restoring shareholder value. Each of our shareholders will now have the opportunity to participate in the future potential of Max Media as an individual Max Media shareholder. "

Mr. Cooper further stated: "Max Media management has committed to filing current financial information in order to achieve transparency for its shareholders and to shorten the holding period on the dividend shares. "

ABOUT MAX MEDIA GROUP (MMG)

MMG operates 10 Hot Web sites including www.hotautoweb.com, www.hotboatweb.com, www.hotplaneweb.com, www.hotcharityweb.com, www.hotrvweb.com and www.hotcycleweb.com, among others. The sites were founded in 2001 with the current management assuming control in January of 2009. In the past 5 years, hotautoweb.com alone has generated $17 million in sales in the Classic Car segment. The Company is now initiating plans to establish a national network of trained independent representatives to market its various website listing services to collectors, charities, consumers and dealers. The Company, as an objective professional 3rd party, enables customers to purchase items (mostly sight unseen) without the fear of hidden defects or problems. The Company allows sellers to bypass the learning curve of how to establish a successful online auction while allowing the seller personal privacy protection all while reaching a worldwide audience of internet buyers with little time or effort.

MMG seeks to become the international premier marketer and publisher of classic cars, higher end vehicles, rv's, boats, motorcycles, planes and other valuable items for individuals, dealers and charities. This will be accomplished by a network of more then 100 independent representatives that complete an exhaustive documentation and history of every item listed with numerous detailed photos, video documentation and the "story," as told by the owner.

MMG revenue is derived from listing fees, both flat rate and percent of sale value, independent representatives subscription fees, and the monetization of website traffic. Currently, MMG generates between $5 to $15 eCPM (dollars earned per 1000 page views).

The management team of MMG consist of:

G. James Grady, CEO. Mr. Grady has over 40 years experience in the automotive industry. Mr. Grady has served as President of Retail Division for Don Olson Tire Centers where he was responsible for the retail operations of over 30 locations throughout the State of Florida. Additionally, he has served as President/CEO for Ken Towery Firestone, Executive V.P. and Franchise Development Manager for Morgan Tire and SE Regional Manager for Franchise Operations and Development for Tuffy Automotive.

Stephen G. Reed, CFO. Mr. Reed has served as a Vice President/Trust and Investment Services Officer for Bank One, Wells Fargo and Fifth Third Bank. Mr. Reed was also an Employee Benefits Consultant for Wausau Insurance Companies.

OTCPicks.com is located at 3533 Twin Lakes Drive, Prosper, TX 75078, Telephone: (972) 546-3740, Email: Publisher@OTCPicks.com.This email address is being protected from spam bots, you need Javascript enabled to view it.

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on OTCPicks.com or one of our affiliate companies.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stockbroker before investing.

Information contained in our report will contain "forward looking statements" as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward-looking statements. These forward-looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company's most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward-looking statements included in the report and not place undue reliance upon such statements. We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company's plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company's operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.

Disclosure: OTCPicks.com has not been compensated by any of the companies covered in this release.